Patrys - Latest News [Page 1]
Patrys to work with CSL to explore antibody drugs
Thursday, 28 January 2010, 2:35 pm | Patrys
Patrys Limited (ASX: PAB), a biopharmaceutical company focused on the development of safer and more effective treatments for cancer and other major diseases, announced today that it had entered into an agreement with CSL Limited (ASX:CSL) that is focused ... More >>
Safety Studies for Lead Products PAT-LM1
Tuesday, 26 May 2009, 4:40 pm | Patrys
Melbourne, Australia; 25 May, 2009: Patrys Limited (ASX: PAB), Australia’s natural human antibody therapy company, advises that it has initiated preclinical safety studies for lead products PAT-LM1 and PAT-SM6. More >>
